More Microba Life Sciences Limited news
Microba Life Sciences LimitedASX: MAP

SYNLAB Agreements Signed in Italy and Portugal

Dec 7, 2022 at 10:24 PM EST · Issued by Microba Life Sciences Limited

Filed with ASX · Dec 7, 2022 at 10:24 PM EST · 2 pages · English

On 6ix: 6ix.com/news/synlab-agreements-signed-in-italy-and-portugal

Watch Microba Life Sciences' latest call↗Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call↗

Microba Life Sciences Limited on 6ix

Earlier from Microba Life Sciences

  • Sonic Investment & Partnership Investor PresentationNov 28, 2022
  • Sonic Acquires 19.9% Microba Stake and Enters PartnershipNov 28, 2022
  • Microba receives $2.62m R&D Tax Incentive refundOct 31, 2022
  • Q1 FY23 Quarterly Activities Report & Appendix 4COct 26, 2022
  • Microba, SYNLAB Extend & Expand DistributionOct 19, 2022

Later from Microba Life Sciences

  • Q2 FY23 Quarterly Activities Report & Appendix 4CJan 29, 2023
  • Positive first animal data for Cancer ProgramJan 31, 2023
  • US Distribution Agreement Signed with Luminary HealthFeb 6, 2023
  • H1 FY23 Interim ReportFeb 22, 2023
  • Microba Launches Next Generation Healthcare TestingFeb 27, 2023
All Microba Life Sciences news releases↗

Follow Microba Life Sciences into a list and get an email when it puts out news.

Follow Microba Life Sciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer